These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 18803281)

  • 21. Expression of transgenic APP mRNA is the key determinant for beta-amyloid deposition in PS2APP transgenic mice.
    Ozmen L; Albientz A; Czech C; Jacobsen H
    Neurodegener Dis; 2009; 6(1-2):29-36. PubMed ID: 19066434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease.
    Olcese JM; Cao C; Mori T; Mamcarz MB; Maxwell A; Runfeldt MJ; Wang L; Zhang C; Lin X; Zhang G; Arendash GW
    J Pineal Res; 2009 Aug; 47(1):82-96. PubMed ID: 19538338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of cyclooxygenase as potential novel therapeutic strategy in N141I presenilin-2 familial Alzheimer's disease.
    Qin W; Peng Y; Ksiezak-Reding H; Ho L; Stetka B; Lovati E; Pasinetti GM
    Mol Psychiatry; 2006 Feb; 11(2):172-81. PubMed ID: 16331303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sevoflurane anesthesia alters exploratory and anxiety-like behavior in mice lacking the beta2 nicotinic acetylcholine receptor subunit.
    Wiklund A; Granon S; Cloëz-Tayarani I; Faure P; le Sourd AM; Sundman E; Changeux JP; Eriksson LI
    Anesthesiology; 2008 Nov; 109(5):790-8. PubMed ID: 18946289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurotoxic mechanisms by Alzheimer's disease-linked N141I mutant presenilin 2.
    Hashimoto Y; Niikura T; Ito Y; Kita Y; Terashita K; Nishimoto I
    J Pharmacol Exp Ther; 2002 Mar; 300(3):736-45. PubMed ID: 11861776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The expression of c-Fos and colocalisation of c-Fos and glucocorticoid receptors in brain structures of low and high anxiety rats subjected to extinction trials and re-learning of a conditioned fear response.
    Lehner M; Wisłowska-Stanek A; Taracha E; Maciejak P; Szyndler J; Skórzewska A; Turzyńska D; Sobolewska A; Hamed A; Bidziński A; Płaźnik A
    Neurobiol Learn Mem; 2009 Nov; 92(4):535-43. PubMed ID: 19596457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation.
    Guix FX; Ill-Raga G; Bravo R; Nakaya T; de Fabritiis G; Coma M; Miscione GP; Villà-Freixa J; Suzuki T; Fernàndez-Busquets X; Valverde MA; de Strooper B; Muñoz FJ
    Brain; 2009 May; 132(Pt 5):1335-45. PubMed ID: 19251756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutant presenilin 2 causes abnormality in the brain lipid profile in the development of Alzheimer's disease.
    Nguyen HN; Son DJ; Lee JW; Hwang DY; Kim YK; Cho JS; Lee US; Yoo HS; Moon DC; Oh KW; Hong JT
    Arch Pharm Res; 2006 Oct; 29(10):884-9. PubMed ID: 17121184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mice transgenic for reduced folate carrier: an animal model of Down syndrome?
    Höger J; Patterson D; Höger H; Shim KS; Bubna-Littitz H; Lubec G
    Amino Acids; 2009 Feb; 36(2):349-57. PubMed ID: 18414976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutant mice with reduced NMDA-NR1 glycine affinity or lack of D-amino acid oxidase function exhibit altered anxiety-like behaviors.
    Labrie V; Clapcote SJ; Roder JC
    Pharmacol Biochem Behav; 2009 Feb; 91(4):610-20. PubMed ID: 18940194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regional brain evaluation of acetylcholinesterase activity in PS1/A246E transgenic mice.
    Jazi R; Lalonde R; Qian S; Strazielle C
    Neurosci Res; 2009 Feb; 63(2):106-14. PubMed ID: 19056437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Limited impact of social isolation on Alzheimer-like symptoms in a triple transgenic mouse model.
    Pietropaolo S; Sun Y; Li R; Brana C; Feldon J; Yee BK
    Behav Neurosci; 2009 Feb; 123(1):181-95. PubMed ID: 19170443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Presenilin 1 and 2 are expressed differentially in the cerebral cortex of mice during development.
    Kumar A; Thakur MK
    Neurochem Int; 2012 Oct; 61(5):778-82. PubMed ID: 22796216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cognitive and non-cognitive behaviors in an APPswe/PS1 bigenic model of Alzheimer's disease.
    Filali M; Lalonde R; Rivest S
    Genes Brain Behav; 2009 Mar; 8(2):143-8. PubMed ID: 19077180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interactions between the anxiogenic effects of CB1 gene disruption and 5-HT3 neurotransmission.
    Mikics E; Vas J; Aliczki M; Halasz J; Haller J
    Behav Pharmacol; 2009 May; 20(3):265-72. PubMed ID: 19421027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased oxidative stress and astrogliosis responses in conditional double-knockout mice of Alzheimer-like presenilin-1 and presenilin-2.
    Zhu M; Gu F; Shi J; Hu J; Hu Y; Zhao Z
    Free Radic Biol Med; 2008 Nov; 45(10):1493-9. PubMed ID: 18822370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Age-related cognitive decline and nesting behavior in an APPswe/PS1 bigenic model of Alzheimer's disease.
    Filali M; Lalonde R
    Brain Res; 2009 Oct; 1292():93-9. PubMed ID: 19643098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Grape seed polyphenols and curcumin reduce genomic instability events in a transgenic mouse model for Alzheimer's disease.
    Thomas P; Wang YJ; Zhong JH; Kosaraju S; O'Callaghan NJ; Zhou XF; Fenech M
    Mutat Res; 2009 Feb; 661(1-2):25-34. PubMed ID: 19027755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Noggin and BMP4 co-modulate adult hippocampal neurogenesis in the APP(swe)/PS1(DeltaE9) transgenic mouse model of Alzheimer's disease.
    Tang J; Song M; Wang Y; Fan X; Xu H; Bai Y
    Biochem Biophys Res Commun; 2009 Jul; 385(3):341-5. PubMed ID: 19463786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Presenilin Mutation Suppresses Lung Tumorigenesis via Inhibition of Peroxiredoxin 6 Activity and Expression.
    Park MH; Yun HM; Hwang CJ; Park SI; Han SB; Hwang DY; Yoon DY; Kim S; Hong JT
    Theranostics; 2017; 7(15):3624-3637. PubMed ID: 29109765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.